Khosla Ventures backs Scipher Medicine
Waltham, Massachusetts-based Scipher Medicine, a developer of a molecular technology platform that can predict if a patient will actually respond to a particular drug therapy has closed its latest funding, raising a total tally of $10 million. Khosla Ventures led the latest round.
7 September 2018•1 min read
